Iceland pushes forward with electronic leaflets
This article was originally published in OTC Bulletin & The Rose Sheet
Introducing electronic patient information leaflets (e-PILs) across Europe would improve patient safety and make trade easier between European countries, according to Einar Magnússon, Iceland’s representative on the Council of Europe’s pharmaceuticals and pharmaceutical care committee, the CD-P-PH.
You may also be interested in...
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.